Jazz Pharmaceuticals (JAZZ) has had a rough couple of weeks. The drugmaker closed at $218.42 on Friday, Oct. 9, down about 11% over the...
Cramer039s
Every market forecast is a chain, and a chain is only as strong as its first link. For most of...
I have been watching Cramer's social media feed long enough to know that when he posts something cryptic about a...
Intel (INTC) has spent years trying to convince investors that its turnaround story is real.For a long time, Wall Street...